ACAD Financial Facts
Net loss: -71.61MCollaborative revenues: 5.27M
See Full Income Statement
See Full Balance Sheet
ACADIA Pharmaceuticals (ACAD) Earnings
|
Expand Research on ACAD
| Next EPS Date | 5/1/24 | EPS Growth Rate | +122.2% |
|---|---|---|---|
| Average EPS % Beat Rate | +22.3% | Revenue Growth Rate | +76.1% |
| Average % Move 1-Wk after EPS | -5.1% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
3/10/11  |
 |
Q410 | $0.74 | $0.69 | +$0.05 | $35.44M | $35.67M | N/A |  | | Details |
| 3/6/12 |
|
Q411 | -$0.10 | -$0.10 | $0.00 | $588K | $550K | N/A | | | Details |
| 11/7/16 |
|
Q316 | -$0.61 | -$0.56 | -$0.05 | $5.3M | $2.9M | N/A | | | Details |
| 7/31/19 | |
Q219 | -$0.38 | -$0.45 | +$0.07 | $93.2M | $72.12M |  |
| | Details |
| 5/4/18 | |
Q118 | -$0.44 | -$0.56 | +$0.12 | $48.9M | $47.06M | = | | | Details |
| 2/29/16 |
|
Q415 | -$0.45 | -$0.38 | -$0.07 | $17K | $60K | N/A | | | Details |
| 5/5/21 | |
Q121 | -$0.42 | -$0.53 | +$0.11 | $106.6M | $111.63M | N/A | | | Details |
| 2/26/19 | |
Q418 | -$0.50 | -$0.55 | +$0.05 | $59.6M | $59.46M | |
| | Details |
